Source:http://linkedlifedata.com/resource/pubmed/id/16306800
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-11-24
|
pubmed:abstractText |
Heart failure after myocardial infarction (MI) is associated with endothelial dysfunction. There is conflicting evidence on the exact nature of this endothelial dysfunction and how endothelium-dependent vasodilation is affected by angiotensin-converting enzyme inhibitor (ACE-I) therapy. Furthermore, consequences of acute ACE-I withdrawal are largely unknown. Therefore, we studied the contribution of nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF) to the effects of ACE-I therapy and its withdrawal on endothelial function in MI rats. Rats were subjected to coronary ligation to induce MI and were assigned to quinapril or vehicle from 2 weeks to 8 months post-MI. In parallel, MI rats treated for 14 months with quinapril were subjected to treatment withdrawal for 0, 4, and 6 weeks. Acetylcholine (ACh)-induced relaxation and underlying endothelium-derived mediators were studied in isolated aortic rings. Long-term quinapril (8 months) resulted in markedly improved endothelium-dependent vasodilation in rats with myocardial infarction, which could be attributed to marked improvement in non-NO/prostanoid-mediated relaxation (ie, EDHF). After 14 months of follow-up, maximum vasodilation was still preserved by quinapril. Withdrawal after 14 months of treatment caused significantly impaired ACh-induced EDHF-mediated relaxation within 4 weeks. A marked reduction in EDHF-mediated relaxation caused this impairment. NO-mediated relaxation was unaffected. These findings highlight the importance of EDHF impairment in development of endothelial dysfunction after myocardial infarction and the possibility of improving EDHF-mediated vasodilation with chronic ACE inhibitor therapy. In addition, withdrawal of chronic ACE inhibition after MI should be considered carefully, as profound endothelial dysfunction may develop rapidly.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine,
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrahydroisoquinolines,
http://linkedlifedata.com/resource/pubmed/chemical/endothelium-dependent...,
http://linkedlifedata.com/resource/pubmed/chemical/quinapril
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0160-2446
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
766-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16306800-Acetylcholine,
pubmed-meshheading:16306800-Aldosterone,
pubmed-meshheading:16306800-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:16306800-Animals,
pubmed-meshheading:16306800-Biological Factors,
pubmed-meshheading:16306800-Endothelium, Vascular,
pubmed-meshheading:16306800-Male,
pubmed-meshheading:16306800-Myocardial Infarction,
pubmed-meshheading:16306800-Rats,
pubmed-meshheading:16306800-Rats, Sprague-Dawley,
pubmed-meshheading:16306800-Tetrahydroisoquinolines,
pubmed-meshheading:16306800-Vasodilation
|
pubmed:year |
2005
|
pubmed:articleTitle |
Improvement of EDHF by chronic ACE inhibition declines rapidly after withdrawal in rats with myocardial infarction.
|
pubmed:affiliation |
Department of Clinical Pharmacology, University Medical Center, Groningen, The Netherlands. b.westendorp@med.umcg.nl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|